Accreditation Information

In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This application-based activity is approved for 1.0 contact hour (0.01 CEUs) of continuing pharmacy education credit (JA0007101-0000-20-005-L01-P).

Objectives

1. Review the most recent molecular testing guidelines for non-small cell lung cancer (NSCLC), including clinically relevant biomarkers, recommended testing modalities, and implications for currently available and evolving treatments.

2. Examine targeted therapies currently approved for NSCLC and appraise biomarker-driven approaches to selection and sequencing of therapy.

3. Using a case-based approach, evaluate adaptive strategies pharmacists can employ to expand the uptake of guideline-recommended biomarker testing and ensure the appropriate selection of targeted therapy based on patient- and biomarker-specific factors.

Target Audience

This activity is designed to meet the educational needs of oncology pharmacists, pharmacy directors, and pharmacy residents attending the 2020 HOPA Annual Conference.

Faculty Disclosure

All planners, speakers, authors, and reviewers involved with content development for continuing education activities provided by Creative Educational Concepts, Inc. are expected to disclose any real or perceived conflict of interest related to the content of the activity. Detailed disclosures will be included in participant materials or given prior to the start of the activity.